DNA Tests

DNA Tests

Services

Marieva MedCare Wellbeing, in collaboration with specialized and scientifically certified
genetic and pharmacogenetic companies, provides modern and reliable genetic testing
services, based on the principles of precision medicine.


Through strategic partnerships with accredited laboratory and scientific organizations, we offer
comprehensive solutions aimed at personalized healthcare, disease prevention, and the
support of clinical decision-making.

DNA Tests

Pharmacogenetic Analysis (PGx – CNS)

Pharmacogenetic analysis (PGx – CNS) examines how an individual’s genetic profile affects
their response to medications related to the central nervous system.
This analysis contributes to:

  • optimization of pharmacological treatment selection
  • reduction of adverse drug reactions
  • support of appropriate dosing
  • enhancement of psychiatric and neurological clinical practice
    Pharmacogenetic analysis is used as a complementary tool and is always applied in
    collaboration with the treating physician.

Genetic Analysis

Genetic analysis provides information regarding genetic predisposition to various health
conditions and contributes to early prevention and personalized health monitoring.
Through this analysis:

  • genetic risk for specific diseases is assessed
  • preventive medicine is supported
  • informed decision-making related to lifestyle and health is enhanced

Nutrigenetic Analysis

Nutrigenetic analysis examines the relationship between genes and nutrition, highlighting how
the body responds to nutrients and dietary patterns.
This service:

  • supports the development of personalized nutritional recommendations
  • contributes to weight management and metabolic regulation
  • identifies dietary sensitivities and intolerances
  • promotes overall wellbeing

Cardiogenetic Analysis

Cardiogenetic analysis focuses on assessing genetic predisposition to cardiovascular
diseases, with the aim of prevention and early intervention.
This analysis:

  • evaluates genetic markers of cardiovascular risk
  • supports preventive cardiology
  • functions as a complementary tool to cardiological assessment
  • does not replace clinical diagnosis or treatment